From Biomarkers to Treatment: The New Need-to-Know in Early Breast Cancer

Download All
Learn from expert faculty as they discuss emerging biomarkers and other recent data changing practice in early breast cancer, including a downloadable slideset from a satellite symposium, an on-demand webcast, and expert commentary.
Heather McArthur, MD, MPH
Program Director
Jennifer K. Litton, MD
Heather McArthur, MD, MPH
Rita Nanda, MD

Downloadable Slidesets

Downloadable slides on individualizing perioperative treatment for patients with high-risk HR-positive and/or germline BRCA–mutated early-stage breast cancer.

Jennifer K. Litton, MD Released: June 3, 2022

Downloadable slides on leveraging immune checkpoint inhibitors for perioperative treatment of patients with early-stage triple-negative breast cancer.

Rita Nanda, MD Released: June 3, 2022

Downloadable slides featuring expert perspectives on clinical challenges and controversies in the rapidly evolving management of early-stage breast cancer.

Heather McArthur, MD, MPH Released: June 3, 2022

On-Demand Webcast

In this on-demand webcast from a live symposium, experts Heather McArthur, MD, MPH; Jennifer K. Litton, MD; and Rita Nanda, MD discuss the most up-to-date guidance on managing early-stage breast cancer.

Heather McArthur, MD, MPH
Program Director
Jennifer K. Litton, MD Rita Nanda, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: June 8, 2022 Expired: June 7, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
Lilly
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings